The new study reverses some of the conclusions of the Women's Health Initiative, a study that made doctors and the general ...
Last week, a new follow-up to the WHI study by the original authors was published in JAMA — and it concluded that it's safe to take hormone therapy for menopause. Here's the thing: While the ...
The use of hormone therapy to relieve menopause symptoms like hot flashes and night sweats is not correlated to a greater risk of death, researchers say. Hormone therapy can reduce bone loss and ...
An older form of hormone therapy taken to ease the symptoms of menopause could increase the risk of ovarian cancer, according to results released Thursday from two studies involving tens of ...
Researchers examined 453 menopausal women aged 40–65 with moderate or severe hot flushes who were unsuitable for hormone replacement therapy, after giving them 45mg of fezolinetant or placebo ...
Moderate to severe hot flashes may triple the risk of metabolic dysfunction steatotic liver disease, a study suggests.
Women who start the menopause before the age of 40 are more likely to die young, new research suggests. Most women experience menopause between the ages of 45 and 55. But around one in 100 go ...
(WJAR) — When it comes to preventing skin cancer and wrinkles, sunscreen is the gold standard -- as long as it works. A new study from the Environmental Working Group, which looked at more than ...
When preliminary results of the Women's Health Initiative clinical trial were published in 2003, they upended menopause care in the U.S. The study linked hormone therapy — a form of treatment for ...
Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of ...